Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COP9 signalosome subunit 2 (COPS2) is a core protein of the COP9 signalosome, an evolutionarily conserved eight-subunit complex that regulates protein turnover by mediating deneddylation of cullin-RING ubiquitin ligases (CRLs). As a transcriptional corepressor, COPS2 binds nuclear hormone receptors and other transcriptional regulators, facilitating gene expression control. In embryonic stem cells, COPS2 maintains pluripotency and cell cycle progression by preventing the proteasomal degradation of Nanog and other critical factors. It also interacts with oncogenic transcription factors (e.g., Snail), influencing tumorigenic signaling pathways. Upregulation and deregulation of COPS2 are implicated in cancer progression, including colorectal and hepatocellular carcinomas, and the protein also plays roles in DNA repair, neuronal differentiation, and early development. Systemic disruption of COPS2 has pronounced effects, including cell cycle arrest and embryonic lethality, making it a promising but challenging therapeutic target[1][2][3][4][5][7].
Drugs targeting the COP9 signalosome would inhibit its protein-deneddylation activity, leading to increased ubiquitin ligase activity and altered protein degradation (especially of oncogenes and tumor suppressors). Indirect regulation of protein turnover (degradation of transcription factors such as Snail, Nanog).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COP9 signalosome subunit 2 (COPS2).